Document is current
Any future updates will be listed below
-
Authors
Kozikowski, Alexander
Wang, Qing https://orcid.org/0000-0002-5829-9522
Yang, Cheng
Gordon, Neil https://orcid.org/0009-0002-5289-7270
Ciociola, Kristina M. https://orcid.org/0009-0007-9519-6286
Yapa, Asanka https://orcid.org/0000-0002-1699-7293
Villa, Claudia
Lambotte, Paul
Pisani, Thomas
Esfandiari, Javan
Gunasekera, Angelo H. https://orcid.org/0000-0001-7766-5818
-
Funding
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
- License Information
-
More Information
Article History
Received: 24 March 2025
Revised: 10 July 2025
Accepted: 29 July 2025
First Online: 21 August 2025
Competing interests
: AK, QW, NG, AY, CV, PL, JE, and AG are current or past employees of Chembio Diagnostics Inc. and have no financial interests or personal relationships that could have influenced the work reported in this paper. CY, KC, and TP are current or past employees of Takeda. Takeda provided financial support. The Takeda authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
: All methods were carried out following relevant guidelines and regulations. The study did not involve any live vertebrate animals; therefore, no ethical approval or reference/registration number was required. All biological samples were obtained from commercial vendors and were fully de-identified, with no identifiable information linked to individuals. As no human research participants were involved in the study, informed consent was not required.
